J Ayurveda Integr Med. 2015 Oct-Dec;6(4):248-58. doi: 10.4103/0975-9476.157951.
Role of chrysin on expression of insulin signaling molecules.
Journal of Ayurveda and integrative medicine
Kottireddy Satyanarayana, Koora Sravanthi, Ivvala Anand Shaker, Rajagopal Ponnulakshmi, Jayaraman Selvaraj
Affiliations
Affiliations
- Department of Medical Biochemistry, Bharath University, Chennai, Tamil Nadu, India.
- Department of Pharmacology, Sakshi Medical College and Research Centre, Guna, Madhya Pradesh, India.
- Department of Zoology, PG and Research, Ethiraj College for Women, Chennai, Tamil Nadu, India.
- Department of Biotechnology, PG and Research, Holy Cross College, Trichy, Tamil Nadu, India.
PMID: 26834424
PMCID: PMC4719485 DOI: 10.4103/0975-9476.157951
Abstract
BACKGROUND: Currently available drugs are unsuccessful for the treatment of tye-2 diabetes due to their adverseside-effects. Hence, a search for novel drugs, especially ofplant origin, continues. Chrysin (5,7-dihydroxyflavone) is a flavonoid, natural component of traditional medicinal herbs, present in honey, propolis and many plant extracts that hasbeen used in traditional medicine around the world to treat numerous ailments.
OBJECTIVE: The present study was aimed to identify the protective role of chrysin on the expression of insulin-signaling molecules in the skeletal muscle of high fat and sucrose-induced type-2 diabetic adult male rats.
MATERIALS AND METHODS: The oral effective dose of chrysin (100 mg/kg body weight) was given once a day until the end of the study (30 days post-induction of diabetes) to high fat diet-induced diabetic rats. At the end of the experimental period, fasting blood glucose, oral glucose tolerance, serum lipid profile, lipid peroxidation (LPO) and free radical generation, as well as the levels of insulin signaling molecules and tissue glycogen in the gastrocnemius muscle were assessed.
RESULTS: Diabetic rats showed impaired glucose tolerance and impairment in insulin signaling molecules (IR, IRS-1, p-IRS-1Tyr(632), p- Akt(Thr308)), glucose transporter subtype 4 [GLUT4] proteins and glycogen concentration. Serum insulin, lipid profile, LPO and free radical generation were found to be increased in diabetic control rats. The treatment with chrysin normalized the altered levels of blood glucose, serum insulin, lipid profile, LPO and insulin signaling molecules as well as GLUT4 proteins.
CONCLUSION: Our present findings indicate that chrysin improves glycemic control through activation of insulin signal transduction in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic male rats.
Keywords: Chrysin; gastrocnemius muscle; high fat diet; insulin signaling; type-2 diabetes
References
- Phytother Res. 2001 Mar;15(2):114-8 - PubMed
- J Biol Chem. 2001 Apr 27;276(17):14459-65 - PubMed
- Phytomedicine. 2001 Mar;8(2):88-93 - PubMed
- Diabetes. 2001 May;50(5):1186-92 - PubMed
- Curr Med Chem. 2001 Jun;8(7):797-807 - PubMed
- Diabet Med. 2002 Jun;19(6):435-9 - PubMed
- Am J Clin Nutr. 2002 Sep;76(3):560-8 - PubMed
- Acta Physiol Scand. 2003 Aug;178(4):373-83 - PubMed
- J Med Food. 2003 Winter;6(4):387-90 - PubMed
- Trends Endocrinol Metab. 2004 Apr;15(3):110-5 - PubMed
- J Nutr Biochem. 2004 Jun;15(6):350-7 - PubMed
- J Biol Chem. 2004 Oct 29;279(44):45304-7 - PubMed
- J Clin Invest. 2005 Mar;115(3):718-27 - PubMed
- Endocrinology. 2006 Aug;147(8):3709-18 - PubMed
- Acta Endocrinol (Copenh). 1990 Mar;122(3):361-8 - PubMed
- J Agric Food Chem. 2006 Oct 18;54(21):8018-26 - PubMed
- Mol Cancer Ther. 2007 Jan;6(1):220-6 - PubMed
- Cell Metab. 2007 Apr;5(4):237-52 - PubMed
- Biochem Biophys Res Commun. 2007 Jul 13;358(4):1102-7 - PubMed
- Horm Metab Res. 2007 Oct;39(10):717-21 - PubMed
- Chem Biol Interact. 2008 Feb 15;171(3):363-8 - PubMed
- Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R673-80 - PubMed
- Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E38-45 - PubMed
- Biochem J. 2008 Jul 15;413(2):201-15 - PubMed
- Diabetes. 2009 Apr;58(4):773-95 - PubMed
- J Fam Pract. 2009 Nov;58(11 Suppl Clinical):S7-14 - PubMed
- Food Chem Toxicol. 2010 Jun;48(6):1654-9 - PubMed
- Nat Med. 2010 Apr;16(4):400-2 - PubMed
- Int J Mol Sci. 2010 Mar 31;11(4):1365-402 - PubMed
- Andrologia. 2012 Jun;44(3):181-6 - PubMed
- FASEB J. 2012 Jun;26(6):2383-93 - PubMed
- Diabetologia. 2012 Jun;55(6):1577-96 - PubMed
- Mol Cell Endocrinol. 2013 Sep 25;378(1-2):15-22 - PubMed
- Indian J Endocrinol Metab. 2012 Jul;16(4):558-64 - PubMed
- J Physiol Biochem. 2013 Jun;69(2):313-23 - PubMed
- Hum Exp Toxicol. 2013 Oct;32(10):1058-66 - PubMed
- Arch Biochem Biophys. 1988 Aug 1;264(2):482-91 - PubMed
- Toxicol Rep. 2014 May 12;1:200-208 - PubMed
- Nature. 1985 Feb 28-Mar 6;313(6005):756-61 - PubMed
- Biochem Biophys Res Commun. 1987 May 29;145(1):134-8 - PubMed
- J Allergy Clin Immunol. 1984 Jun;73(6):819-23 - PubMed
- Cell Immunol. 1981 Apr;59(2):301-18 - PubMed
- Proc Natl Acad Sci U S A. 1982 Nov;79(22):6792-6 - PubMed
- J Nutr. 1981 Mar;111(3):531-6 - PubMed
- Pharmacol Biochem Behav. 1994 Jan;47(1):1-4 - PubMed
- Nature. 1995 Dec 21-28;378(6559):785-9 - PubMed
- AIDS Res Hum Retroviruses. 1996 Jan 1;12(1):39-46 - PubMed
- Am J Physiol. 1996 Apr;270(4 Pt 1):E667-76 - PubMed
Publication Types